文献速递免疫规划传染病防控与疫情报告

13价肺炎球菌结合疫苗全身免疫后经鼻黏膜免疫磷酸胆碱可增强抗肺炎链球菌免疫应答

Phosphorylcholine intranasal immunization with a 13-valent pneumococcal conjugate vaccine can boost immune response against Streptococcus pneumoniae.
PubMed 文献 · Vaccine · 2019-10-24

本研究在小鼠中先腹腔注射13价肺炎球菌结合疫苗(PCV13),两周后分组比较再次腹腔注射PCV13与经鼻黏膜免疫磷酸胆碱(PC)-匙孔血蓝蛋白联合霍乱毒素的效果。结果显示两组抗疫苗株肺炎链球菌血清IgG滴度相似,但PC经鼻免疫组抗PC血清IgG、鼻洗液PC特异性IgA及鼻黏膜PC特异性IgA分泌细胞数均显著更高,并增强中耳细菌清除。结论认为PCV13后追加PC经鼻免疫可产生与追加全身免疫相当的加强效应及PC特异性黏膜免疫应答。

要点

  • PCV13全身免疫后经鼻黏膜免疫PC可诱导显著更高的血清抗PC IgG和鼻黏膜PC特异性IgA。
  • 两组抗疫苗株肺炎链球菌血清IgG滴度相似,但PC经鼻免疫组中耳细菌清除增强。
  • 作者认为PC经鼻免疫可提供针对PCV13未覆盖血清型的保护。

核心结论

  • PCV13免疫后追加PC经鼻免疫可产生与追加全身免疫相当的加强效应,并诱导PC特异性黏膜免疫应答,从而提供针对PCV13未覆盖血清型的保护。

研究设计与样本

  • 小鼠实验:腹腔注射PCV13两周后分为两组,一组再次腹腔注射PCV13,另一组经鼻黏膜免疫PC-匙孔血蓝蛋白联合霍乱毒素作为黏膜佐剂。

主要发现

  • 抗疫苗株肺炎链球菌血清IgG抗体滴度在PCV13全身免疫组与PC经鼻免疫组间相似。
  • 抗PC血清IgG抗体滴度在PC经鼻免疫组显著高于PCV13全身免疫组。
  • 鼻洗液PC特异性IgA抗体滴度及鼻黏膜PC特异性IgA分泌细胞数在PC经鼻免疫组均显著更高。
  • PC经鼻免疫组诱导的PC特异性IgA增强了中耳细菌清除。

临床怎么用

  • 作者认为,在目前周期性疫苗接种规划中PCV13免疫后追加PC经鼻免疫可产生加强效应及PC特异性黏膜免疫应答。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to investigate whether systemic immunization with a 13-valent pneumococcal conjugate vaccine (PCV13) followed by intranasal (IN) immunization with phosphorylcholine (PC) can boost immune response against Streptococcus pneumoniae. MATERIALS AND METHODS: Two weeks after the intraperitoneal (IP) injection of PCV13, mice were divided into two groups (mice requiring another IP injection of PCV13 and mice requiring PC-keyhole limpet hemocyanin IN immunization in combination with cholera toxin as a mucosal adjuvant) to compare the magnitude of systemic and mucosal immune responses against S. pneumoniae and PC. RESULTS: Serum immunoglobulin (Ig) G antibody titer against the vaccine strains of S. pneumoniae was similar between the PCV13 systemic immunization group and PC IN immunization group, while the serum IgG antibody titer against PC was significantly higher in the PC IN immunization group. PC-specific IgA antibody titer in the nasal lavage and PC-specific IgA-producing cell number in the nasal mucosa were also significantly higher in the PC IN immunization group. Induction of PC-specific IgA in the PC IN immunization group enhanced the clearance of bacteria from the middle ear. CONCLUSION: Additional IN immunization with PC after PCV13 immunization, which is currently conducted under a periodic vaccination program, can produce a booster effect comparable to that achieved by additional systemic immunization as well as PC-specific mucosal immune response, thereby providing protection against S. pneumoniae serotypes not contained in PCV13.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ohori J, Iuchi H, Maseda Y, et al. Phosphorylcholine intranasal immunization with a 13-valent pneumococcal conjugate vaccine can boost immune response against Streptococcus pneumoniae. Vaccine. 2019. PMID: 31668823. doi:10.1016/j.vaccine.2019.10.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。